Doktorlar

PROF.DR. ERTUĞRUL ERCAN

Eğitim ve Uzmanlık

  • 1988 - LİSANS - EGE ÜNİVERSİTESİ TIP FAKÜLTESİ
  • 1994 - Y. LİSANS - EGE ÜNİVERSİTESİ İÇ HASTALIKLARI
  • 1997 - Y. LİSANS EGE ÜNİVERSİTESİ KARDİYOLOJİ
  • 2007 - DOÇENT DOKTOR - ÇANAKKALE ONSEKİZ MART ÜNİVERSİTESİ TIPTA UZMANLIK
  • 2009 - PROFOSÖR DOKTOR - ÇANAKKALE ONSEKİZ MART ÜNİVERSİTESİ TIPTA UZMANLIK

Hastalıklar

  • Kapakçık Hastalıkları
  • Koroner Arter Hastalığı
  • Girişimsel Kardiyoloji
  • Hipertansiyon
  • Ateroskleroz
  • Kök Hücre Tedavisi
  • Kardiyovasküler Hastalıklarda İmmünoloji
  • İnflmasyon ve Koagulasyon İlişkisi

Deneyim

  • 1994-1997 - İç Hastalıkları ABD Tıp Fakültesi Ege Üniversitesi     
  • 1997-2000 - Kardiyoloji ABD Tıp Fakültesi Ege Ünivesitesi
  • 2000-2001 - Kardiyoloji ABD Tıp Fakültesi Ege Ünivesitesi Bölümü
  • 2001-2007 - Central Hospital, Kardiyoloji Bölümü
  • 2002   Eylül-Kasım - Cleveland Clinic, Dept. Of Cardiology
  • 2003  Şubat-Mayıs - İstanbul Üniv. Çapa Tıp Fak. Kardiyoloji ABD. Elektrofizyoloji Lab
  • 2009 Kasım - Melbourne, Avusturalya
  • Çanakkale Onsekiz Mart Üniversitesi Tıp Fakültesi Kardiyoloji AD Başkanlığı
  • Çanakkale Onsekiz Mart Üniversitesi Tıp Fakültesi Eğitim Komisyonu,
  • Çanakkale Onsekiz Mart Üniversitesi Tıp Fakültesi Erasmus Akademik Birim Koordinatörü,
  • Çanakkale Onsekiz Mart Üniversitesi Tıp Fakültesi Etik Kurulu,
  • Çanakkale Onsekiz Mart Üniversitesi Tıp Fakültesi Dekan Yardımcılığı
  • Çanakkale Onsekiz Mart Üniversitesi Sağlık Hizmetleri Meslek Yüksek Okulu Müdürlüğü
  • Çanakkale Onsekiz Mart Üniversitesi Araştırma Uygulana Hastanesi Başhekimliği
  • Çanakkale Onsekiz Mart Üniversitesi Tıp Fakültesi Dekanlığı
  • İzmir Medical Point Hastanesi Tıbbi Direktörlüğü

Mesleki Üyelikleri

  • Türk Kardiyoloji Derneği
  • Vascular Biology Working Group              
  • Interventional Cardiology, Working Group, ESC
  • European Association of Percutaneous Cardiovascular Interventions
  • European Cardiologist Diploma                                                
  • Hypertension Specialist                                               
  • Fellow of European Society of Cardiology
  • Hipertansiyonla Mücadele Derneği
  • Türk Hipertansiyon ve Ateroskleroz Derneği
  • Türk Kardiyoloji Derneği Konjenital Çalışma Grubu Üyeliği,
  • Türk Kardiyoloji Derneği İnvaziv Çalışma Grubu Üyeliği,

Araştırma Yayınları

1. SCI, SCI-Expanded SSCI ve AHCI kapsamında yer alan dergilerde yayımlanan ;

a. Özgün araştırma, makale, derleme

  • 1: Gurgun C, Ercan E, Ceyhan C, Yavuzgil O, Zoghi M, Aksu K, Cinar CS, Turkoglu C. Cardiovascular involvement in Behcet's disease. Jpn Heart J. 2002 Jul;43(4):389-98.        
  • 2: Onbasili OA, Tekten T, Ceyhan C, Ercan E, Mutlu B. A new echocardiographic method for the assessment of the severity of aortic regurgitation: color M-mode flow propagation velocity. J Am Soc Echocardiogr. 2002 Dec;15(12):1453-60.              
  • 3: Alioglu E, Turk U, Cam S, Abbasaliyev A, Tengiz I, Ercan E. Polymorphisms of the methylenetetrahydrofolate reductase, vascular endothelial growth factor,endothelial nitric oxide synthase, monocyte chemoattractant protein-1 and apolipoprotein E genes are not associated with carotid intima-media thickness. Can J Cardiol. 2009 Jan;25(1):e1-5.
  • 4: Ercan E, Baris N, Tengiz I, Ercan HE, Onbasili OA, Duman C, Cinar CS. Femoral signal intensity: a new method for prediction of embolic risk. Jpn Heart J. 2003 Sep;44(5):705-12.
  • 5: Duman C, Ercan E, Tengiz I, Bozdemir H, Ercan HE, Nalbantgil I. Elevated serum CA 125 levels in mitral stenotic patients with heart failure. Cardiology. 2003;100(1):7-10.  
  • 6: Ercan E, Tengiz I, Ercan HE, Nalbantgil I. Left ventricular hypertrophy and endothelial functions in patients with essential hypertension. Coron Artery Dis. 2003 Dec;14(8):541-4.
  • 7: Ercan E, Tengiz I, Duman C, Onbasili OA, Baris N. Effect of tirofiban on C-reactive protein in non-ST-elevation myocardial infarction. Am Heart J. 2004 Jan;147(1):E1. 
  • 8: Tekten T, Ceyhan C, Ercan E, Onbasili AO, Turkoglu C. The effect of atorvastatin on platelet function in patients with coronary artery disease. Acta Cardiol. 2004 Jun;59(3):311-5.
  • 9: Ercan E, Tengiz I, Duman C, Sekuri C, Aliyev E, Mutlu B, Ercan HE, Akin M.  Decreased plasminogen activator inhibitor-1 levels in coronary artery aneurysmatic patients. J Thromb Thrombolysis. 2004 Jun;17(3):207-11. 
  • 10: Berdeli A, Sekuri C, Sirri Cam F, Ercan E, Sagcan A, Tengiz I, Eser E, Akin M. Association between the eNOS (Glu298Asp) and the RAS genes polymorphisms and premature coronary artery disease in a Turkish population. Clin Chim Acta. 2005 Jan;351(1-2):87-94.
  • 11: Cam SF, Sekuri C, Tengiz I, Ercan E, Sagcan A, Akin M, Berdeli A. The G894T polymorphism on endothelial nitric oxide synthase gene is associated with premature coronary artery disease in a Turkish population. Thromb Res. 2005;116(4):287-92. Epub 2005 Jan 16.
  • 12: Sekuri C, Cam FS, Ercan E, Tengiz I, Sagcan A, Eser E, Berdeli A, Akin M. Renin-angiotensin system gene polymorphisms and premature coronary heart disease. J Renin Angiotensin Aldosterone Syst. 2005 Mar;6(1):38-42.
  • 13: Boydak B, Nalbantgil S, Fici F, Nalbantgil I, Zoghi M, Ozerkan F, Tengiz I, Ercan E. A randomized comparison of the effects of nebivolol and atenolol with and without chlorthalidone on the sexual function of hypertensive men,” Clin Drug Invest, 25 (6), 409-416 (2005).
  • 14: Ercan E, Tengiz I, Duman C, Nalbantgil I.  Investigation of flow-mediated dilation response in normal coronary angiographic patients. Angiology. 2005 Nov-Dec;56(6):671-5
  • 15: Ergun M, Tengiz I, Turk U, Senisik S, Alioglu A, Yuksel O, Ercan E, Islegen Ç. The effects of long-term regular exercise on endothelial functions, inflammatory and thrombotic activity in middle-aged, healthy men. Journal of Sports science and medicine 2006:5;266-275
  • 16: Sekuri C, Cam FS, Sagcan A, Ercan E, Tengiz I, Alioglu E, Berdeli A. No association of interleukin-6 gene polymorphism (-174 G/C) with premature coronary artery disease in a Turkish cohort. Coron Artery Dis. 2007 Aug;18(5):333-7.
  • 17: Tamer GS, Tengiz I, Ercan E, Duman C, Alioglu E, Turk UO. Helicobacter pylori Seropositivity in Patients with Acute Coronary Syndromes. Dig Dis Sci. 2008 Sep 4
  • 18: Cam SF, Sekuri C, Sagcan A, Ercan E, Tengiz I, Alioglu E, Berdeli A. Effect of monocyte chemoattractant protein-1 (MCP-1) gene polymorphism in Turkish patients with premature coronary artery disease. Scand J Clin Lab Invest. 2008 Jul 24:1-5.
  • 19: Türk U, Alioğlu E, Tengiz I, Ercan E, Mahmudov R, Duygu H, Türkoğlu C. Statin use is associated with decreased CD-40 ligand expression on T lymphocytes of coronary atheroma plaque in patients with stable coronary artery disease. Anadolu Kardiyol Derg. 2008 Apr;8(2):99-103
  • 20: Alioglu E, Turk UO, Bicak F, Tengiz I, Atila D, Barisik V, Ercan E, Akin M. Vascular endothelial functions, carotid intima-media thickness, and soluble CD40 ligand levels in dipper and nondipper essential hypertensive patients. Clin Res Cardiol. 2008 Jul;97(7):457-62
  • 21: Alioğlu E, Ercan E, Tengiz I, Yildiz A, Onsel Türk U, Saygi S, Cam FS, Berdeli A. G protein beta3 subunit gene polymorphism in Turkish hypertensives. Anadolu Kardiyol Derg. 2008 Oct;8(5):331-5
  • 22: Tamer GS, Tengiz I, Ercan E, Duman C, Alioglu E, Turk UO. Helicobacter pylori seropositivity in patients with acute coronary syndromes. Dig Dis Sci. 2009 Jun;54(6):1253-6. Epub 2008 Sep 4
  • 23: Sekuri C, Cam FS, Sagcan A, Ercan E, Tengiz I, Alioglu E, Berdeli A. No association of interleukin-6 gene polymorphism (-174 G/C) with premature coronary artery disease in a Turkish cohort. Coron Artery Dis. 2007 Aug;18(5):333-7.
  • Ercan E. Microalbuminuria, is a cardiovascular risk factor? Trakya Universitesi Tıp Fakültesi Dergisi, baskıda
  • 25: Alioğlu E, Ercan E, Tengiz I, Türk UO, Ergün M, Akgöz S, Işlegen C, Berdeli A. The influence of α-adducin gene polymorphism on response of blood pressure to exercise in patients with hypertension. Anadolu Kardiyol Derg. 2010 Oct;10(5):400-4.
  • 26: Kirilmaz B, Asgun F, Alioglu E, Ercan E, Tengiz I, Turk U, Saygi S, Ozerkan F. High inflammatory activity related to the number of metabolic syndrome components. J Clin Hypertens. 2010 Feb 1;12(2):136-44.
  • 27: Turk U, Alioglu E, Kirilmaz B, Duygu H, Tuzun N, Tengiz I, Zoghi M, Ercan E. Prediction of head-up tilt test result: is it possible? Pacing Clin Electrophysiol. 2010 Feb;33(2):153-8. Epub 2009 Nov 2.

b.Editöre mektup, teknik not, tartışma, vaka takdimi ve özet türünden yayınlar

  • 1: Ozgen AG, Ercan E, Ozutemiz O, Hamulu F, Bayraktar F, Yilmaz C. The 4A syndrome association with osteoporosis. Endocr J. 1999 Feb;46(1):227-30.
  • 2: Ceyhan C, Ercan E, Tekten T, Kirilmaz B, Onder R. Myocardial infarction following a bee sting. Int J Cardiol. 2001 Sep-Oct;80(2-3):251-3.
  • 3: Ercan E, Tengiz I, Yakut N, Gurbuz A, Bozdemir H, Aydin M. A novel technique for occlusion of large branch of internal mammary artery graft. Int J Cardiol. 2003 Nov;92(1):99-100.
  • 4: Ercan E, Tengiz I, Yakut N, Gurbuz A. Large atherosclerotic left main coronary aneurysm: a case report and review of literature. Int J Cardiol. 2003 Mar;88(1):95-8.
  • 5: Tekten T, Onbasili OA, Ceylan C, Ercan E. Left atrial free floating ball thrombus in hypertrophic cardiomyopathy: a case report. J Am Soc Echocardiogr. 2002 Sep;15(9):1018-20
  • 6: Ercan E, Tengiz I, Yakut N, Gurbuz A, Bozdemir H, Bozdemir G. Takayasu's arteritis with multiple fistulas from three coronary arteries to lung paranchima. Int J Cardiol. 2003 Apr;88(2-3):319-20.
  • 7: Ercan E. Mixed apical left ventricular hypertrophic cardiomyopathy with surrenal adenoma. Int J Cardiol. 2004 Oct;97(1):165-6.
  • 8: Ceyhan C, Tekten T, Onbasili OA, Ercan E. Transient ischemic attack with apical hypertrophic cardiomyopathy. Jpn Heart J. 2003 Mar;44(2):285-9.
  • 9: Ercan E. Specific glycoprotein IIb/IIIa antagonists and inflammation. Int J Cardiol. 2004 Mar;94(1):121-2.
  • 10: Ercan E, Tengiz I, Sekuri C, Aliyev E, Etemoglu M, Sari S, Akin M.  Transbrachial coil occlusion of the large branch of an internal mammary artery coronary graft. J Card Surg. 2004 Jan-Feb;19(1):45-6.
  • 11: Tengiz I, Aliyev E, Ercan E. An alternative percutaneous interventional approach for post-anastomatic left anterior descending artery stenosis in patients with markedly tortuous LIMA graft. Int J Cardiovasc Imaging. 2005 Oct;21(5):491-4.
  • 12: Tengiz I, Ercan E, Turk UO. Percutaneous Myocardial Ablation for Left Mid-Ventricular Obstructive Hypertrophic Cardiomyopathy. Int J Cardiovasc Imaging. 2006 Feb;22(1):8-13.
  • 13: Tengiz I, Ercan E, Alioglu E, Turk UO. Percutaneous septal ablation for left mid-ventricular obstructive hypertrophic cardiomyopathy: a case report. BMC Cardiovasc Disord. 2006 Apr 10;6:15
  • 14: Türk UO, Alioğlu E, Ercan E, Duygu H. Abnormal elongated chordae tendinea protruding to the left ventricular outflow tract. Anadolu Kardiyol Derg. 2009 Apr 10;9(2):E5
  • 15: Alioglu E, Ercan E, Sonmez Tamer G, Duman C, Turk U, Tengiz I, Tuzun N, Saygi S. Decreased circulatory erythropoietin in hyperacute phase of myocardial ischemia. Int J Cardiol. 2009 Jan 24.
  • 16: Saygı S, Alioğlu E, Türk U, Tüzün N, Kırılmaz B, Tengiz I, Ercan E. Thrombotic occlusion of a left main coronary artery in a patient with prosthetic mitral valve. Anadolu Kardiyol Derg. 2010 Dec;10(6):553-4. doi: 10.5152/akd.2010.170.
  • 17: Alioglu E, Tuzun N, Sahin F, Kosova B, Saygi S, Tengiz I, Turk U, Ozsan N, Ercan E. Non ST-segment elevation myocardial infarction in patient with essential thrombocythemia. Thromb J. 2009 Feb 20;7:1.

2. SCI, SCI-Expanded, SSCI ve AHCI dışındaki uluslararası indeksler tarafından taranan hakemli dergilerde yayımlanan
a.Özgün araştırma, makale,derleme

  • 1: Onbasili OA, Tekten T, Ceyhan C, Ercan E. Ultrasonic integrated backscatter analysis in patients with dilated cardiomyopathy: comparison with healthy individuals Anadolu Kardiyol Derg. 2002 Mar;2(1):4-11
  • 2: Tekten T, Onbasili OA, Ceyhan C, Ercan E. The relationship of the left atrial spontaneous echo contrast integrated backscatter with left atrial appendix function and tissue doppler characteristics. Anadolu Kardiyol Derg. 2002 Jun;2(2):113-8
  • 3 Sekuri C, Cam FS, Tengiz I, Ercan E, Bayturan O, Berdeli A. Association of platelet-activating factor acetylhydrolase gene polymorphism with premature coronary artery disease in Turkish patients. Anadolu Kardiyol Derg. 2006 Jun;6(2):132-4.
  • 4: Ercan E, Bozdemir H, Tengiz I, Sekuri C, Aliyev E, Akilli A, Akin M. Decreased soluble cell adhesion molecules after tirofiban infusion in patients with unstable angina pectoris. Thromb J. 2004 Apr 1;2(1):4.
  • 5: Ercan E, Tengiz I, Altuglu I, Sekuri C, Aliyev E, Ercan HE, Akin M.  Atorvastatin treatment decreases inflammatory and proteolytic activity in patients with hypercholesterolemia. Kardiol Pol. 2004 May;60(5):454-8.
  • 6: Tengiz I, Ercan E, Aliyev E, Sekuri C, Duman C, Altuglu I. Elevated levels of matrix metalloprotein-3 in patients with coronary aneurysm: A case control study. Curr Control Trials Cardiovasc Med. 2004 Oct 13;5(1):10.
  • 7: Tengiz I, Ercan E, Sahin F, Alioglu E, Duman C, Saydam G, Buyukkececi F.  Presence of factors that activate platelet aggregation in mitral stenotic patients' plasma. Curr Control Trials Cardiovasc Med. 2005 Feb 27;6(1):2.
  • 8: Ercan E, Ceyhan C, Gurgun C, Tekten T, Onbasıili A, Turkoglu C. The effects of cholesterol lowering theraphy with atorvastatin on flow-mediated dilation in patients with hypercholesterolemic coronary artery disease. Kardiol Pol. 2001 Dec;55(12):503-508.
  • 9: Ceyhan C, Ercan E, Ceyhan C, Yavuzgil O, Zoghi M, Aksu K, Turkoglu C. Transosephageal echocardiographic findings of cardiac involvement in behçets disease. Kardiol Pol. 2001 May;54(1): 332-334.

b.Editöre mektup, teknik not, tartışma, vaka takdimi ve özet türünden yayınlar

  • 1: E. Ercan ve I. Tengiz, “Idiopathic radial artery aneurysm,” Anadolu Kardiyol Derg, 3 (3), 287 (2003).
  • 2:  E. Ercan ve I. Tengiz, “Mid-ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm,” Anadolu Kardiyol Derg, 4 (1), 105 (2004).
  • 3: Ercan E, Tengiz I, Aliyev E ve Kurhan Z, “Single coronary artery arising from the right sinus of Valsalva,” Anadolu Kardiyol Derg, 4 (2), 195 (2004).
  • 4:  Ercan E, Tengiz I, Sekuri C, Sahin F, Aliyev E, Akin M, Acikel U.  Cardiac thrombi in a patient with protein-C and S deficiencies: a case report. Thromb J. 2004 Mar 28;2(1):2.
  • 5: Alioglu E, Tuzun N, Sahin F, Kosova B, Saygi S, Tengiz I, Turk U, Ozsan N, Ercan E. Non ST-segment elevation myocardial infarction in patient with essential thrombocythemia. Thromb J. 2009 Feb 20;7:1.

3.Ulusal hakemli bilimsel dergilerde yayımlanan ; 


a. Özgün araştırma, makale ve derleme

 

  • Tengiz, E. Ercan, N. Yakut, A. Gürbüz ve I. Nalbantgil, Hiperakut miyokard infarktüsü ve bir dakikalık kalp hızı değişkenliği testi, Türk Kardiyol Dern Arş, 30, 616-620 (2002).
  • Ercan, I. Tengiz, H.E. Ercan, A. Akıllı, I. Nalbantgil, G. Bozdemir ve O. Durmaz, Kararsız Anjina Pektorisli Hastalarda Hücre Adezyon Molekülleri düzeyi ile Koroner Arter Hastalığı Yaygınlığının İlişkisi, Türk Kardiyol Dern Arş, 31, 136-140 (2003).
  • Tengiz, E. Ercan ve I. Nalbantgil, “Diyastolik kalp yetersizliği: Etyoloji ve patofizyoloji,” İ. Ü. Kardiyol Enst Derg, 2, 45-49 (2003).
  • Ercan, I. Tengiz, S. Nalbantgil ve I. Nalbantgil, “Hasta sinus sendromu,” Geriatri, 6, 109-112 (2003).
  • Duman, S. Erdoğan, F. Yıldız, İ. Başyiğit, İ. Meram, S.S. Göçmez, L. Yücesoy, İ. Tengiz, H.E. Ercan, E. Aliyev, E. Ercan ve M. Çekmen, “Sigara içen kişilerde filtreli ağızlık kullanımı nikotin maruziyetini azaltır mı?,” Abant İzzet Baysal Üniversitesi Düzce Tıp Fakültesi Dergisi, 1, 13-16 (2003).
  • Tengiz, E. Ercan, N. Barış, S. Güneri ve I. Nalbantgil, “Koroner Arter Hastalığının Ciddiyeti ile Endotel Disfonksiyonu Arasındaki İlişki,” Türk Kardiyol Dern Arş, 31, 198-203 (2003).
  • Ercan, I. Tengiz, M.B. Çekmen, “Kardiovasküler sistemde nitrik oksit ve nitrik oksit sentaz: Fizyolojik ve patofizyolojik özellikleri,” I. Ü. Kardiyol Enst Derg, 2, 36-41 (2003).
  • Ercan, I. Tengiz, A. Akıllı ve I. Nalbantgil, “Vasküler girişim şekilleri ve komplikasyonları,” T Klin J Cardiol, 16, 419-424 (2003).
  • Ercan, I. Tengiz ve I. Nalbantgil, “Diyastolik kalp yetersizliği: Klinik ve ekokardiyografik tanı,” T Klin J Cardiol, 16, 433-438 (2003).
  • Yalçın, C. Duman, M.B. Çekmen, B. Çetinarslan, Z. Cantürk, S. Erdoğan, H.K. Özdoğan, İ. Tengiz ve E. Ercan, “Hipertiroidili hastalarda propiltiyourasil tedavisinin nitrik oksit, oksidan ve antioksidanlar üzerine etkileri,” Türk Klinik Biyokimya Derg, 1, 1-6 (2005).
  • Ercan, İ. Tengiz, E. Aliyev, C. Şekuri, M. Akın ve İ. Nalbantgil, “Kararsız Anjina Pektorisli Hastalarda İnflamasyon ve Elektrokardiyografik Değişiklikler,” İ. Ü. Kardiyol Enst Derg, 3, 24-27 (2004).
  • İ. Tengiz ve E. Ercan, “Obstrüktif uyku apnesi sendromu ve hipertansiyon,” Türk Kardiyoloji Seminerleri, 620-630 (2004).
  • Ercan, C. Duman, M.B. Çekmen, İ. Tengiz, B. Yalçın, H.E. Ercan, M. Akın ve S. Erdoğan, “Hafif romatizmal mitral stenozlu hastalarda malondialdehid ve nitrik oksit düzeyleri,” Anadolu Tıp Dergisi, 1, 1-6 (2005).
  • Aliyev, İ. Tengiz, E. Ercan, C. Şekuri, M. Tümüklü, M. Akın ve İ. Nalbantgil, “Tip II diyabetik hastalarda plazma homosistein düzeyleri ile koroner arter hastalığı ve endotel disfonksiyonu varlığı arasındaki ilişki,” Türkiye Klinikleri J Med Sci, 25, 609-616, (2005).
  • 15 Alioğlu E, Türk U, Ercan E. Kardiak resenkronizasyon tedavisi için uygun adayların belirlenmesinde ekokardiyografi. TAPE, 2008 Ekim, 5(3), 217-225
  • 16 U Onsel Turk, Alioğlu E, Ercan E. Gebelik ve kalp yetmezliği. J Cardiol Special topics 2008, 1(2):122-128
  • E. Aliyev, E. Ercan. Enfeksiyonlar ve kardiyak nedenler dışındaki hastalıklara bağlı EKG değişiklikleri,” Türkiye Klinikleri J Med Sci, 2006,2(33):56-59
  • Ercan E, Alioglu E, Turk U, Sonmez Tamer G, Duman C, Tengiz I, Gocer H. “Effects of myocardial ischemia on serum erythropoietin levels during the first six hours of balloon angioplasty,” J. Card. Res., 3, 46-53 (2006).

 

b.Teknik not, editöre mektup, tartışma, vaka takdimi ve özet türünden yayınlar

 

  • Tengiz, E. Ercan, N. Yakut, A. Akıllı ve Ü. Ertürk, Multipl koroner arteriyovenöz fistüllerin koil embolizasyonu istenilen sonucu verebilir mi?, Türk Göğüs Kalp Damar Cer Derg, 10, 184-186 (2002).
  • İ. Tengiz, E. Ercan, E. Aliyev ve R. Mahmudov, “Kink oluşturmuş aortik greft,” Türk Kardiyol Dern Arş, 32, 52 (2004).
  • İ. Tengiz, E. Aliyev, U. Ö. Türk ve E. Ercan, “Noncompaction of the ventricular myocardium with tetralogy of Fallot,” Anadolu Kardiyol Derg.
  • Tengiz I, Duygu H, Turk U, Ercan E, Nalbantgil S. A case of left atrial myxoma as a cause of platypnea. Anadolu Kardiyol Derg. 2006 Sep;6(3):301.
  • Türk U, Alioğlu E, Tengiz I, Ercan E. Atypical Mitral Annular Calcification Mimicking Intracardiac Tumour. Türk Kardiyol Dern Arş, Baskıda
  • Emin Alioglu, Ugur O. Turk, Abbasali Abbasaliyev, Istemihan Tengiz ve Ertugrul Ercan. “Percutaneous transluminal angioplasty and stenting of proximal right subclavian artery stenosis in a patient with syncope,” J. Card. Res., 3, 42-47 (2006).
  • Emin Alioğlu, Uğur Önsel Türk, İstemihan Tengiz ve Ertuğrul Ercan, “A case of left ventricular hydatid cyst,” Arch Turk Soc Cardiol, 35(5), 295-298 (2007).

 

c.Sanat Dallarındaki Etkinlikler

4.Kongre Sunuları

Uluslararası kongre, sempozyum, çalıştay, konferans, panel gibi bilimsel toplantılarda sunularak, programda yer alan ;

a. SCI, SCI-Expanded, SSCI ve AHCI kapsamındaki dergi özel sayılarında veya aynı kapsamdaki kongre kitaplarında özet metin olarak yayınlanan bildiri, poster veya gösteri

  • Gürgün, C. S. Çınar, C. Ceyhan, İ. Alat, M. Zoghi, E. Ercan, L. Can, C. Türkoğlu, “Cardiac myxoma: clinical and echocardiographic features in 14 cases,” The second annulal and preliminary meeting of the working group on echocardiography of the ESC, December, 9-12 (1998).
  • Zoghi, C. Gürgün, E. Ercan, F. Özerkan, H. Evrengül, L. Can, A. Akıllı, S. Payzın, H. Kültürsay, “QT dispersion in patients with different etiology of left ventricular hypertrophy,” XXI st. Congress of the European Society of Cardiology, August 28th –September 1st, Barcelona, Spain (1999).
  • Gürgün, M. Zoghi, F. Özerkan, C. Ceyhan, E. Ercan, C. S. Çınar, C. Türkoğlu, “The relationship between spontaneous echocontrast and microembolic signals established with transcranial Doppler ultrasonography,” XXI st congress of the European Society of Cardiology, August 28th –September 1st, Barcelona, Spain (1999).
  • Gürgün, E. Ercan, C. Ceyhan, M. Zoghi, F. Özerkan, K. Aksu, Z. Danaoğlu, C. Çınar, C. Türkoğlu, “Transesophageal echocardiographic findings of cardiac involvement in Behçet’s disease,” XXII nd congress of the European Society of Cardiology August 26-30, Amsterdam, the Netherlands, (2000).
  • E Ercan, C. Gürgün, C. Ceyhan, M. Zoghi, A. Akıllı, S. Payzın, L. Can, M. Akın, C. Türkoğlu, “The effect of cholesterol lowering therapy with atorvastatin on flow mediated vasodilatation in patients with hypercholesterolemic coronary artery disease,” XXII nd congress of the European Society of Cardiology, August 26-30, Amsterdam, the Netherlands, (2000).
  • Zoghi, C. Gürgün, F. Özerkan, E. Ercan, O. Yavuzgil, A. Akıllı, S. Payzın, C. Türkoğlu. The effect of exercise on P wave and QT dispersion in coronary artery disease: an angiographic correlation. XXII nd congress of the European Society of Cardiology August 26-30 2000 Amsterdam, the Netherlands
  • Tekten, A. Onbasili, C. Ceyhan, E. Ercan, O. Senturk, “Cyclic variation of integrated backscatter and myocardial wall thickness during percutaneous transluminal coronary angioplasty,” XXIII. st Congress of the European Society of Cardiology, Sweden, Oral presentation, (2001).
  • Onbasili, T. Tekten, E. Ercan, C. Ceyhan, O. Senturk, “A new echocardiographic method for the assessment of the severity of aortic regurgitation: color M mode flow propagation velocity,” XXIII. st Congress of the European Society of Cardiology, Sweden, Oral presentation, (2001).
  • Ercan, C. Ceyhan, T. Tekten, N. Baris, C. Cinar, “Femaral arterial echocontrast: A new method detecting the presence of left atrial spontaneous echocontrast,” XIVth World Congress of Cardiology, Suppl JACC, Sydney, Oral presentation, May 5-9, (2002).
  • Tekten, A. O. Onbaşılı, C. Ceyhan, E. Ercan, P. Agaoglu, T. Piskin, “Tissue doppler myocardial performance index,” XIVth World Congress of Cardiology, Suppl Journal of JACC, Sydney, May 5-9, Oral presentation, (2002).
  • E Ercan, H Bozdemir, C Ceyhan , T Tekten, A Onbasılı, I Altugoglu, G Bozdemir, A Akilli, “Glycoprotein IIb/IIIa antagonists and inflammation; a new effect mechanism in patients with unstable angina pectoris,” XXIII. st Congress of the European Society of Cardiology, Berlin, Oral presentation, (2002).
  • Ceyhan, H. Akar, T. Tekten, A. O. Onbaşılı, E. Ercan, M. Kaya, N. Ozgel, “Cyclic variation of the integrated backscatter signal in essential hypertensive patients with microalbuminuria,” XXIII. st Congress of the European Society of Cardiology, Berlin, (2002).
  • Onbaşılı, T. Tekten, C. Ceyhan, E. Ercan, T. Piskin, “The effect of heart rate on the color M-mode doppler flow propogation velocity and pressure half time in aortic insufficiency,” XXIII. st Congress of the European Society of Cardiology, Berlin, (2002).
  • Ercan, I. Tengiz, C. Duman, H. Bozdemir, Z. Kurhan, N. Baris, “The effect of tirofiban on C-reactive protein levels in non-ST elevation myocardial infarction,” XXIV. st Congress of the European Society of Cardiology, Vienna, Austria, (2003).
  • Ercan, I. Tengiz, I. Altuglu, C. Duman, “Effect of atorvastatin on serum matrix metalloproteinase acticity in hypercholesterolemic adults,” XXIV. st Congress of the European Society of Cardiology, Vienna, Austria, (2003).
  • Ercan, I. Tengiz, C. Duman, H. Bozdemir, Z. Kurhan, N. Baris, “The effect of tirofiban on C-reactive protein levels in non-ST-elevation myocardial infarction”, XXIV. st Congress of the European Society of Cardiology, Vienna, Austria, 2003
  • Ercan, I. Tengiz, I. Altuglu, C. Duman, “Effect of atorvastatin on serum matrix metalloproteinase acticity in hypercholesterolemic adults”, XXIV. st Congress of the European Society of Cardiology, Vienna, Austria, 2003
  • Tengiz, E. Ercan, C. Sekuri, E. Aliyev, S. Saygı, S. Guneri, M. Akin, I. Nalbantgil, “The relationship between severity of coronary artery disease and endothelial dysfunction”, xxv. st Congress of the European Society of Cardiology, Munich, Germany, 2004
  • Sekuri, F.S. Cam, I. Tengiz, A. Sagcan, E. Ercan, M. Akin ve A. Berdeli, “No association of IL-6 gene polymorphism (-174 G/C) with premature coronary artery disease,” 75th European Atherosclerosis Society Congress, Prague, Czech Republic, 2005.
  • 20 E. Ercan, C. Duman, G. S. Tamer, I. Tengiz, Alioglu, U. O. Turk, C Sekuri, Sirri C., Decreased epo levels after cardiac ischemia. World Cardiology Congress,  Barcelona, 2006
  • 21 FS Cam, C Sekuri, A Sagcan, E Ercan, I Tengiz, E Alioglu, A Berdeli. Lack of association between MCP-1 gene polymorphism and premature coronary artery disease. 77th congress of the European atherosclerosis society 2008, İstanbul, Turkey
  • 22 E. Alioglu, E. Ercan, I. Tengiz, U. Turk, M. Ergun, S. Akgoz, C. Islegen, A. Berdeli, “The influence of alpha-adducin gene polymorphism on response of blood pressure to exercise in patients with hypertension” Congress of the European Society of Cardiology, Munich, Germany, 2008.